Fevertree Drinks' recent strategic partnership with Molson Coors is set to accelerate its growth in the U.S. See why FQVTF ...

This was the stock's second consecutive day of gains.

Citi analyst Filippo Falorni upgraded Molson Coors (NYSE:TAP) stock rating from Sell to Neutral and increased the price ...

Molson Coors will pay £71m ($88m) for an 8.5% stake in Fever-Tree Drinks Plc: a deal which sent Fever-Tree shares soaring ...

TAP expands its non-alcoholic portfolio with a strategic partnership and investment in Fever-Tree, targeting growth in the ...

Greenleaf Trust lowered its position in shares of Molson Coors Beverage (NYSE:TAP – Free Report) by 12.9% during the fourth ...

Fever-Tree is already the largest tonic and ginger beer brand in the US by value: but the brand believes there’s still huge ...

Molson Coors Brewing (TAP) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...

Citi upgraded Molson Coors (TAP) to Neutral from Sell with a price target of $57, up from $47. The firm says its fundamental thesis has largely ...

A deal with a brewer on Molson Coors’ scale is transformational. Elevated glass and transatlantic freight costs have dragged ...

The Coors Light manufacturer’s 8.5% stake in the nonalcoholic carbonated mixer further builds on its long-term strategy of ...

Molson Coors Beverage Company (NYSE:TAP) has formed a strategic alliance with Fever-Tree Drinks plc to broaden its portfolio ...